Novo Integrated Sciences Inc. Faces Delisting from Nasdaq, Begins Trading on OTC Market
I'm PortAI, I can summarize articles.
Novo Integrated Sciences Inc. is facing delisting from Nasdaq due to a violation of the minimum bid price requirement. As of November 6, 2024, its stock will begin trading on the OTC Market under the symbol "NVOS." Nasdaq will file a Form 25 with the SEC to finalize the delisting, which will take effect 10 days after the filing. In the meantime, the company's stock will continue to be quoted on the OTC Market.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments